Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
New Pfizer and Moderna Covid-19 vaccines approved by US
03:58am, Friday, 23'rd Aug 2024
US regulators have approved a new series of updated and improved COVID-19 vaccines to target a resurgence of the virus as new strains emerge. Pfizer Inc (NYSE:PFE, ETR:PFE) and Moderna Inc (NASDAQ:MR
CAMBRIDGE, MA / ACCESSWIRE / August 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for a partial c
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Moderna, Inc.(MRNA) Shareholders
08:30pm, Thursday, 22'nd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK, Aug. 22, 2024 /PRNewswire/ -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed agai
Moderna, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
06:30pm, Thursday, 22'nd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
S&P 500 Gains and Losses Today: Moderna Falls Despite Approval of New COVID Shot
06:00pm, Thursday, 22'nd Aug 2024
Major U.S. equities indexes fell Thursday as the Jackson Hole Economic Policy Symposium kicked off in Wyoming. Federal Reserve Chair Jerome Powell is scheduled to speak just after the markets open on
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
Updated COVID-19 vaccines from Pfizer, Moderna approved by FDA
02:41pm, Thursday, 22'nd Aug 2024
The Food and Drug Administration on Thursday gave Pfizer Inc. and Moderna Inc. approval for updated COVID-19 vaccines, as a summer wave of the virus is still rolling across the country.
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
01:47pm, Thursday, 22'nd Aug 2024
Spikevax 2024-2025 formula expected to be available in pharmacies and care settings across the U.S. in the days immediately following approval CAMBRIDGE, MA / ACCESSWIRE / August 22, 2024 / Moderna, I
FDA approves updated Pfizer, Moderna Covid vaccines as virus surges; shots to be available within days
01:36pm, Thursday, 22'nd Aug 2024
The Food and Drug Administration approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach most Americans in the coming days as the virus surges. The jabs target a s
Class Action Filed Against Moderna, Inc. (MRNA) - October 8, 2024 Deadline to Join – Contact Levi & Korsinsky
01:18pm, Thursday, 22'nd Aug 2024
NEW YORK, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA) of a class action securities lawsuit.
Shareholders that lost money on Moderna, Inc.(MRNA) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
11:15am, Thursday, 22'nd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
Shareholders With Losses In Moderna Inc. Are Encouraged To Join A Lawsuit For Securities Fraud With The Schall Law Firm
11:00am, Thursday, 22'nd Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Moderna, Inc. ("Moderna" or "th
Investors in Moderna, Inc. Should Contact Levi & Korsinsky Before October 8, 2024 to Discuss Your Rights - MRNA
10:30am, Thursday, 22'nd Aug 2024
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / If you suffered a loss on your Moderna, Inc. (NASDAQ:MRNA) investment and want to learn about a potential recovery under the federal securities laws, foll
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Moderna, Inc. ("Moderna" or the "Company") (NASDAQ:MRNA) and certain officers.
